Back
Fortress Biotech Vs. Phathom Pharmaceuticals Industry Stock Comparison
Sell
37
FBIO
Fortress Biotech
Last Price:
1.73
Seasonality Move:
21.92%
Buy
55
PHAT
Phathom Pharmaceuticals
Last Price:
18.52
Seasonality Move:
-6.37%
Sell
37
Fortress Biotech (FBIO)
is a Sell
Is Fortress Biotech a Buy, Sell or Hold?
- The current Fortress Biotech [FBIO] share price is $1.76. The Score for FBIO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- FBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $18.00. The Score for PHAT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FBIO Stock Price Chart
What is Fortress Biotech's stock price today?
-
The Fortress Biotech share price today is $1.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBIO is experiencing slight buying pressure.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $18.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
FBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 48.6 | Sell |
| Chaikin Money Flow: | 97657 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.61 - 1.89) | Buy |
| Bollinger Bands (100): | (1.61 - 2.07) | Sell |
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 57.02 | Buy |
| Chaikin Money Flow: | -868822 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.7 - 17.76) | Buy |
| Bollinger Bands (100): | (11.4 - 17.4) | Buy |
FBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.88 | Sell |
| 20-day SMA: | 1.79 | Sell |
| 50-day SMA: | 1.75 | Buy |
| 200-day SMA: | 1.86 | Sell |
| 8-day EMA: | 1.82 | Sell |
| 20-day EMA: | 1.79 | Sell |
| 50-day EMA: | 1.78 | Sell |
| 200-day EMA: | 2.37 | Sell |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.85 | Buy |
| 20-day SMA: | 16.68 | Buy |
| 50-day SMA: | 17.21 | Buy |
| 200-day SMA: | 11.91 | Buy |
| 8-day EMA: | 17.81 | Buy |
| 20-day EMA: | 17.23 | Buy |
| 50-day EMA: | 16.41 | Buy |
| 200-day EMA: | 13.18 | Buy |
Fortress Biotech Earnings Growth & FBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.48 per share, and an increase next year of $1.78 per share.
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
Fortress Biotech Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Phathom Pharmaceuticals Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||